Analysis of multidisciplinary treatment using chemotherapy, carbon ion therapy, and surgery for stage II and III esophageal cancer
Not Applicable
- Conditions
- Stage II and III esophageal cancer
- Registration Number
- JPRN-UMIN000049296
- Lead Sponsor
- ational Institutes for Quantum Sciences and Technology QST Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 27
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients with a history of radiotherapy at the irradiation site. (2) Active double cancer in other organs. (3) Active interstitial pneumonia. (4) Active and intractable infection in the planned irradiation area. (5) HBs antigen, HCV antibody. HIV antibody and HTLV antibody positive. (6) Cases judged inappropriate by the principal investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse reactions in normal tissues
- Secondary Outcome Measures
Name Time Method